Trexquant Investment’s Epirus Biopharmaceuticals EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-47,846
Closed -$428K – 1456
2015
Q1
$428K Buy
+47,846
New +$384K 0.04% 743

Other funds holding EPRS

Trexquant Investment's EPRS Position: Q2 2015 in Review

Trexquant Investment sold out of Epirus Biopharmaceuticals (EPRS) in Q2 2015, closing a stake of 47,846 shares — an estimated $428K sold.

Trexquant Investment first reported a position in EPRS in Q1 2015 and held it in 1 quarter. The position peaked at $428K in Q1 2015. 41 funds tracked by Wall St. Rank hold EPRS as of Q2 2015.

  • Trexquant Investment reported no remaining Epirus Biopharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Trexquant Investment sold 47,846 Epirus Biopharmaceuticals shares in Q2 2015, an estimated $428K.
  • Trexquant Investment first reported a position in Epirus Biopharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Trexquant Investment's Epirus Biopharmaceuticals position peaked at $428K in Q1 2015.
  • 41 funds tracked by Wall St. Rank held Epirus Biopharmaceuticals as of Q2 2015.

Based on Trexquant Investment's 13F filing for Q2 2015, filed 12 Aug 2015.